(MENAFN- GlobeNewsWire - Nasdaq) New Quantexa AI capabilities give enterprises and government agencies the trusted data and contextual intelligence required to deploy agentic AI safely, at scale, and ...

As power companies build hybrid projects combining solar, wind, battery storage and hydrogen assets, they face the challenge of integrating dozens of different control systems and data types from ...

Ripple has completed its purchase of global prime broker Hidden Road and rebranded the business as Ripple Prime, a bundled trading, financing and clearing desk for institutions, the company announced ...

Prime editing is a powerful genome-editing technology that can achieve any possible base substitution, insertion, or deletion without the requirement for double strand breaks. However, challenges ...

The exception has rarely been used in copyright cases, but the judge presiding over an OpenAI dispute with copyright owners has granted a motion to compel discovery in the past. Register for free to ...

Terry has 25 years experience in journalism and communications, reporting on a range of topics that include personal finance, telecommunications, Congress, government regulations, and criminal justice ...

Welcome back to The Prompt. Stanford PhDs Fan-Yun Sun and Sharon Lee cofounded AI research company Moonlake AI to help people "vibe code virtual worlds." Artificial intelligence is facing an ...

SAN JOSE — A significant chunk of land and buildings next to a site where Microsoft is eyeing possible data centers in north San Jose was purchased for $200 million, documents show. Affordable housing ...

Seeing the “too many redirects” page pop up isn’t just a browser error, it’s also a silent SEO killer. Every time a URL sends a visitor or search engine crawler to another URL automatically—called a ...

The prime suspect in Madeleine McCann's disappearance claims he holds information that could solve "the scandal of the century." The convicted pedophile boasted to shop workers that he could crack one ...

Prime Medicine (NASDAQ: PRME) has had a lot to celebrate in recent months, explaining a surge that has seen the prime editing therapy developer’s stock more than double this year, including a 22% jump ...